New preclinical research suggests that bowel preparation procedures for colonoscopies may temporarily alter gut balance, ...
Series A expected to advance lead asset Mucosal-Immune Modulator CS-0003 through Phase II in GI surgical site infections and expand a differentiated GI mucosal-immune pipeline and metabolomics-driven ...
New preclinical research suggests that bowel preparation procedures for colonoscopies may temporarily alter gut balance, ...
Founded in 1985, Mentor, Ohio-based STERIS plc (STE) develops, manufactures and markets infection prevention, decontamination ...